Robot-assisted Gait Training on Mobility in Severely Disabled Multiple Sclerosis Patients

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Multiple Sclerosis
Interventions
DEVICE

Robot-assisted gait training

Patients will receive 12 training sessions, lasting for an hour with 30 minutes of real walking time, over 4 weeks (3 sessions/week) of RAGT. Subjects will wear a harness attached to a system to provide body weight support and they will walk on a treadmill with the help of a robotic-driven gait orthosis. The legs are guided according to a physiological gait pattern. The torque of the knee and hip drives can be adjusted from 100% to 0% for one or both legs. The speed of the treadmill can be adjusted from 0 km/h to approximately 3 km/h and body weight support from 0% to 100%. During the first session we will set these parameters according to subject characteristics and demand level. As training will progress, adjustments in the three parameters previously described will be performed.

OTHER

Conventional therapy

The control group will receive 12 conventional therapy sessions over 4 weeks (3 sessions/week), that will focus on gait training. Subjects will receive 1 hour of individual conventional physiotherapy for session. During the first 5-10 minutes the subjects will perform lower-limb and core stretching exercises to increase muscles flexibility; then they'll deal with lower-limb muscles strengthening exercises tailored on their baseline characteristics (10 minutes). After that, assisted over-ground walking training will be performed.

Trial Locations (1)

Unknown

Ferrara University Hospital, Ferrara

All Listed Sponsors
collaborator

Regione Emilia-Romagna

OTHER

collaborator

Università degli Studi di Ferrara

OTHER

lead

University Hospital of Ferrara

OTHER

NCT02421731 - Robot-assisted Gait Training on Mobility in Severely Disabled Multiple Sclerosis Patients | Biotech Hunter | Biotech Hunter